455 related articles for article (PubMed ID: 18776926)
21. Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
Leger C; Sabloff M; McDiarmid S; Bence-Bruckler I; Atkins H; Bredeson C; Zhang H; Huebsch L
Ann Hematol; 2006 Oct; 85(10):723-9. PubMed ID: 16832675
[TBL] [Abstract][Full Text] [Related]
22. Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation.
Samaras P; Buset EM; Siciliano RD; Haile SR; Petrausch U; Mischo A; Honegger H; Pestalozzi BC; Schanz U; Stussi G; Stahel RA; Knuth A; Renner C; Stenner-Liewen F
Oncology; 2010; 79(1-2):93-7. PubMed ID: 21079406
[TBL] [Abstract][Full Text] [Related]
23. High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity study.
Ager S; Mahendra P; Richards EM; Bass G; Baglin TP; Marcus RE
Bone Marrow Transplant; 1996 Mar; 17(3):335-40. PubMed ID: 8704683
[TBL] [Abstract][Full Text] [Related]
24. Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
Hunter A; Mahendra P; Wilson K; Fields P; Cook G; Peniket A; Crawley C; Hickling R; Marcus R
Bone Marrow Transplant; 2009 Apr; 43(7):563-9. PubMed ID: 18997832
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
Dix S; Cord M; Howard S; Coon J; Belt R; Geller R
Bone Marrow Transplant; 1999 Sep; 24(5):561-6. PubMed ID: 10482943
[TBL] [Abstract][Full Text] [Related]
26. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation.
Bolwell BJ; Kalaycio M; Sobecks R; Andresen S; Kuczkowski E; Bernhard L; Lomax R; Kohuth J; Mendiola S; Rybicki L; Pohlman B
Bone Marrow Transplant; 2002 Nov; 30(9):587-91. PubMed ID: 12407433
[TBL] [Abstract][Full Text] [Related]
27. A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.
Phillips GL; Bernstein SH; Liesveld JL; Abboud CN; Becker MW; Constine LS; Ifthikharuddin JJ; Loughner JE; Milner LA; Vesole DH; Friedberg JW
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1033-42. PubMed ID: 21074630
[TBL] [Abstract][Full Text] [Related]
28. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
[TBL] [Abstract][Full Text] [Related]
29. High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.
Buser AS; Stern M; Bucher C; Arber C; Heim D; Halter J; Meyer-Monard S; Stussi G; Lohri A; Ghielmini M; Tichelli A; Passweg JR; Gratwohl A
Bone Marrow Transplant; 2007 Mar; 39(6):335-40. PubMed ID: 17342158
[TBL] [Abstract][Full Text] [Related]
30. LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy.
Khattry N; Gupta A; Jain R; Gore A; Thippeswamy R; Jeevangi N; Kannan S; Nair R; Saikia T
Int J Hematol; 2016 Mar; 103(3):292-8. PubMed ID: 26729297
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation.
Kim JG; Sohn SK; Kim DH; Baek JH; Chae YS; Bae NY; Kim SY; Lee KB
Transplant Proc; 2005 Dec; 37(10):4488-91. PubMed ID: 16387151
[TBL] [Abstract][Full Text] [Related]
32. Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation.
Oblon DJ; Paul SR; Oblon MB; Malik S
Bone Marrow Transplant; 1997 Dec; 20(11):961-3. PubMed ID: 9422475
[TBL] [Abstract][Full Text] [Related]
33. Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
Gil L; Kozlowska-Skrzypczak M; Mol A; Poplawski D; Styczynski J; Komarnicki M
Bone Marrow Transplant; 2009 Jan; 43(2):121-6. PubMed ID: 18794866
[TBL] [Abstract][Full Text] [Related]
34. A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
Russell N; Mesters R; Schubert J; Boogaerts M; Johnsen HE; Canizo CD; Baker N; Barker P; Skacel T; Schmitz N
Haematologica; 2008 Mar; 93(3):405-12. PubMed ID: 18268285
[TBL] [Abstract][Full Text] [Related]
35. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
Chen J; Seabrook J; Fulford A; Rajakumar I
J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
[TBL] [Abstract][Full Text] [Related]
36. Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation.
Spencer A; Horvath N; Gibson J; Prince HM; Herrmann R; Bashford J; Joske D; Grigg A; McKendrick J; Prosser I; Lowenthal R; Deveridge S; Taylor K;
Bone Marrow Transplant; 2005 May; 35(10):971-7. PubMed ID: 15778725
[TBL] [Abstract][Full Text] [Related]
37. Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells.
Weaver CH; Zhen B; Buckner CD
Bone Marrow Transplant; 1998 Jun; 21(11):1169-70. PubMed ID: 9645585
[No Abstract] [Full Text] [Related]
38. [Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].
Imataki O; Aoyama T; Tamai Y; Kawakami K
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1633-6. PubMed ID: 17940379
[TBL] [Abstract][Full Text] [Related]
39. BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy.
Jantunen E; Kuittinen T; Nousiainen T
Leuk Lymphoma; 2003 Jul; 44(7):1151-8. PubMed ID: 12916867
[TBL] [Abstract][Full Text] [Related]
40. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation.
McGuire DB; Altomonte V; Peterson DE; Wingard JR; Jones RJ; Grochow LB
Oncol Nurs Forum; 1993; 20(10):1493-502. PubMed ID: 8278277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]